| ID | 10143 |
| Vaccine Name | Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted |
| Disease Name | Influenza (flu) |
| Disease Classification | Respiratory |
| Virus Name | Influenza A virus H5N1 |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Inactivated |
| Vaccine Status | Approved |
| Manufacturer | ID Biomedical Corporation of Quebec |
| Year of Manufacturing | 2013 |
| Manufacturing Country | USA |
| Age | 6 months and above |
| Dosage | 2 doses 21 days apart |
| Administration Route | Intramuscular |
| Adjuvant | AS03 |
| Target Strain | A/H5N1 influenza antigen |
| Description | NA |
| Approving Organisation | US FDA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NA |
| Reference Link | https://www.fda.gov/media/87479/download |
| Additional Links | https://www.fda.gov/vaccines-blood-biologics/vaccines/influenza-h5n1-virus-monovalent-vaccine-adjuvanted
|